^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

KDR expression

i
Other names: VEGFR2, KDR, Vascular Endothelial Growth Factor Receptor 2, Protein-Tyrosine Kinase Receptor Flk-1, Fetal Liver Kinase 1, FLK1, CD309, CD309 Antigen
Entrez ID:
Related biomarkers:
Phase 1
Bracco Diagnostics, Inc
Completed
Last update posted :
08/01/2023
Initiation :
07/01/2010
Primary completion :
12/01/2012
Completion :
12/01/2012
KDR
|
KDR expression
Phase 2
Sun Yat-sen University
Not yet recruiting
Last update posted :
09/14/2020
Initiation :
09/01/2020
Primary completion :
10/01/2022
Completion :
10/01/2023
PD-L1 • KDR
|
PD-L1 expression • KDR expression
|
AiRuiKa (camrelizumab) • AiTan (rivoceranib)
Phase 2
Sun Yat-sen University
Not yet recruiting
Last update posted :
09/14/2020
Initiation :
09/01/2020
Primary completion :
10/01/2022
Completion :
10/01/2023
PD-L1 • KDR
|
PD-L1 expression • KDR expression
|
AiRuiKa (camrelizumab) • AiTan (rivoceranib)
Phase 1
Amsterdam UMC, location VUmc
Unknown status
Last update posted :
10/02/2019
Initiation :
02/01/2014
Primary completion :
03/01/2021
Completion :
05/01/2021
KDR • CD31 • PECAM1
|
KDR expression • VEGFA expression
|
Avastin (bevacizumab)
Phase 2
Northwestern University
Completed
Last update posted :
09/09/2019
Initiation :
03/06/2013
Primary completion :
05/27/2015
Completion :
12/28/2016
KDR • FLT1
|
KDR expression • FLT1 expression
|
Fotivda (tivozanib)
Phase 3
Hoffmann-La Roche
Completed
Last update posted :
02/05/2018
Initiation :
05/23/2011
Primary completion :
01/27/2013
Completion :
08/17/2017
KDR • VEGFA
|
KDR expression
|
Avastin (bevacizumab) • carboplatin • paclitaxel
Phase N/A
Peking University People's Hospital
Not yet recruiting
Last update posted :
12/05/2017
Initiation :
02/01/2018
Primary completion :
02/01/2021
Completion :
02/01/2024
PD-L1 • KDR
|
PD-L1 expression • KDR expression